Come up with a name for your new list and we'll add to it:
Avidex raised a round of funding on , . Investors include
Advent Venture Partners.
Avidex is a spin out from Oxford University. The company is developing T-Cell receptors for use in stem cell research focused on cures for various diseases including cancers, osteoporosis, and multipl…